Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass  Minna Ilmakunnas, MD, Eero J. Pesonen,

Slides:



Advertisements
Similar presentations
Of mice and men and surgical transcatheter aortic valve insertion
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Microvascular fluid exchange during pulsatile cardiopulmonary bypass perfusion with the combined use of a nonpulsatile pump and intra-aortic balloon pump 
Building a bioartificial heart: A 3-song saga
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bicuspid aortic valve aortopathy: One size fits all?
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
The lord of the rings  Antonio Miceli, MD, PhD 
Hypogammaglobulinemia after cardiopulmonary bypass in infants
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
The variability of the mitral valve anatomy and terminology
Support Your Specialty
Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design
Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Which is better to preserve pulmonary function: Short-term or prolonged leukocyte depletion during cardiopulmonary bypass?  Kaiyu Tao, MD, Qi An, MD,
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Replicating the success of mitral valve repair in the aortic valve
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
The Ross procedure: Time to reevaluate the guidelines
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
Hans-Joachim Schäfers, MD 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Between a rock and a hard place
Bicuspid aortopathy: Seeing the forest for the trees
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD 
Elevated flow rate during cardiopulmonary bypass is associated with fluid accumulation  Oddbjørn Haugen, MD, Marit Farstad, MD, PhD, Venny Kvalheim, MD,
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Managing conflicts of interest
More than vital: Who bears the burden?
Repetition is the mother of skill
Preoperative PFTs: The answer is blowing in the wind
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Did you like Terminator 3 better than Terminator 2
Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury  Christine S Rinder, MD, Manuel Fontes, MD,
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Zipping up after a median sternotomy: Are we at the end of the wire?
Deciding how much to pay for effective care
Presentation transcript:

Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass  Minna Ilmakunnas, MD, Eero J. Pesonen, MD, PhD, Jouni Ahonen, MD, PhD, Juhani Rämö, MD, PhD, Sanna Siitonen, MD, PhD, Heikki Repo, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 129, Issue 4, Pages 851-859 (April 2005) DOI: 10.1016/j.jtcvs.2004.07.061 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Neutrophil (PMN, A) and monocyte (B) counts in control and filter groups. Boxes indicate 25th and 75th percentiles and central lines indicate median, with whiskers representing range. 0, Before surgery; pre CPB, immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’ CPB, 30 minutes of CPB; declamp, immediately before aortic declamping; 5’ declamp, 5 minutes after aortic declamping, post CPB, 5 minutes after CPB. For both neutrophil and monocyte counts, P < .001 between groups, P < .001 time effect within groups, 1-way repeated measures ANOVA. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 851-859DOI: (10.1016/j.jtcvs.2004.07.061) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Neutrophil (A) and monocyte (B) CD11b expressions in control and filter groups. Boxes indicate 25th and 75th percentiles and central lines indicate median, with whiskers representing range. 0, Before surgery; pre CPB, immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’ CPB, 30 minutes of CPB; declamp, immediately before aortic declamping; 5’ declamp, 5 minutes after aortic declamping, post CPB, 5 minutes after CPB. For both neutrophil and monocyte CD11b expressions, P < .001 between groups, P < .001 time effect within groups, 1-way repeated measures ANOVA. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 851-859DOI: (10.1016/j.jtcvs.2004.07.061) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Neutrophil (A) and monocyte (B) L-selectin expressions in control and filter groups. Boxes indicate 25th and 75th percentiles and central lines indicate median, with whiskers representing range. 0, Before surgery; pre CPB, immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’ CPB, 30 minutes of CPB; declamp, immediately before aortic declamping; 5’ declamp, 5 minutes after aortic declamping, post CPB, 5 minutes after CPB. For both neutrophil and monocyte L-selectin expressions, P < .001 between groups, 1-way repeated measures ANOVA. Neutrophil L-selectin expression increased significantly in control group (time effect P < .001) but did not change significantly with time in filter group (P = .067). Monocyte L-selectin expression increased in control group (time effect P < .001), but less so in filter group (time effect P =.014). The Journal of Thoracic and Cardiovascular Surgery 2005 129, 851-859DOI: (10.1016/j.jtcvs.2004.07.061) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Neutrophil hydrogen peroxide production measured as DCF fluorescence (A) and plasma concentration of lactoferrin (B) in control and filter groups. Boxes indicate 25th and 75th percentiles and central lines indicate median, with whiskers representing range. 0, Before surgery; pre CPB, immediately before CPB; 5’ CPB, 5 minutes of CPB; 30’ CPB, 30 minutes of CPB; declamp, immediately before aortic declamping; 5’ declamp, 5 minutes after aortic declamping, post CPB, 5 minutes after CPB. For both neutrophil hydrogen peroxide production and plasma lactoferrin concentration, P < .001 between groups, P < .001 time effect within groups, 1-way repeated measures ANOVA. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 851-859DOI: (10.1016/j.jtcvs.2004.07.061) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions